Join the Bronchitis group to help and get support from people like you.
Bronchitis News
Digital Tool Potentially Predicts Childhood Asthma
TUESDAY, June 17, 2025 — A new digital tool can flag kids who are at risk for developing childhood asthma, researchers report. The tool scans electronic health data records and calculates an asthma r...
Exposure to Smoke Pollution Ups Risk for Hospitalization for Respiratory Disease
FRIDAY, May 2, 2025 – For older adults in the Western United States, exposure to high levels of smoke pollution is associated with an increase in hospitalizations for respiratory diseases, according...
Nearly Half of Americans Breathe Unhealthy Air, New Report Finds
FRIDAY, April 25, 2025 — Breathing the air in nearly half of the United States could be putting the health of residents at risk. A new American Lung Association report shows that 156 million people l...
Risk for Meniere Disease Increased With Upper Respiratory Infections
MONDAY, Nov. 4, 2024 – Individuals with a history of upper respiratory infections (URI) have an increased risk for developing Meniere disease (MD), according to a study published online Oct. 10 in...
Wildfires Are Gaining Speed in Western U.S., Upping Threat to People
FRIDAY, Oct. 25, 2024 – Wildfires that spread so fast they outrun the efforts of fire crews trying to contain them: These types of conflagrations are becoming far more common across the Western...
Americans Are Moving Away From Polluted Areas -- If They Can Afford To
MONDAY, Aug. 26, 2024 – Americans of means are fleeing heavily polluted places in the United States for cleaner locales, a new study has found. Pollution levels are a factor in families’ decision to ...
Childhood Air Pollution Exposure Tied to Later Bronchitic Symptoms
THURSDAY, July 25, 2024 – Childhood exposure to air pollution is associated with adult bronchitic symptoms, according to a study published online June 25 in the American Journal of Respiratory and ...
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single i...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones:...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections
ISSUE: FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated...
FDA Approves Tudorza Pressair to Treat Chronic Obstructive Pulmonary Disease
July 23, 2012 – The U.S. Food and Drug Administration today approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm (narrowing of the airways in the...
FDA Approves Arcapta Neohaler to treat Chronic Obstructive Pulmonary Disease
The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in...
Further information
Related drug support groups
amoxicillin, doxycycline, Mucinex, azithromycin, Bactrim, Cipro, ciprofloxacin, Zithromax, Augmentin, view more... Levaquin, levofloxacin, erythromycin, clarithromycin, guaifenesin, amoxicillin / clavulanate, cefdinir, sulfamethoxazole / trimethoprim, Bactrim DS, Rocephin, tetracycline